1.
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial
by Colombel, Jean-Frederic
The Lancet (British edition), 2017, Vol.390 (10114), p.2779-2789
2.
Golimumab, a human antibody to tumour necrosis factor α given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study
by Keystone, E C
Annals of the rheumatic diseases, 2009, Vol.68 (6), p.789-796
3.
AMPK and mTOR in Cellular Energy Homeostasis and Drug Targets
by INOKI, Ken
Annual review of pharmacology and toxicology, 2012, Vol.52 (1), p.381-400
4.
Disease-specific oligodendrocyte lineage cells arise in multiple sclerosis
by Falcão, Ana Mendanha
Nature medicine, 2018, Vol.24 (12), p.1837-1844
5.
Effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in patients with Crohn's disease or ulcerative colitis who had failed conventiona...
by Colombel, J.‐F. J.‐F.
Alimentary pharmacology & therapeutics, 2016, Vol.45 (1), p.50-62
6.
Evidence-based clinical practice guidelines for inflammatory bowel disease 2020
by Nakase, Hiroshi
Journal of gastroenterology, 2021, Vol.56 (6), p.489-526
7.
Mushroom immunomodulators: unique molecules with unlimited applications
by El Enshasy, Hesham A
Trends in biotechnology (Regular ed.), 2013, Vol.31 (12), p.668-677
8.
9.
Usefulness of co-treatment with immunomodulators in patients with inflammatory bowel disease treated with scheduled infliximab maintenance therapy
by Sokol, Harry
Gut, 2010, Vol.59 (10), p.1363-1368
10.
Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis
by Buch, Maya H
Annals of the Rheumatic Diseases, 2011, Vol.70 (6), p.909-506
11.
β-glucans as potential immunoadjuvants: A review on the adjuvanticity, structure-activity relationship and receptor recognition properties
by Jin, Yiming
Vaccine, 2018, Vol.36 (35), p.5235-5244
12.
Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined result...
by Manzi, Susan
Annals of the rheumatic diseases, 2012, Vol.71 (11), p.1833-1838
13.
Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strat...
by Dougados, Maxime
Annals of the rheumatic diseases, 2013, Vol.72 (1), p.43-50
14.
A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis...
by Quartier, Pierre
Annals of the rheumatic diseases, 2011, Vol.70 (5), p.747-754
15.
Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response
by van Vollenhoven, Ronald F
Annals of the rheumatic diseases, 2012, Vol.71 (8), p.1343-1349
16.
IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24...
by Emery, P
Annals of the Rheumatic Diseases, 2008, Vol.67 (11), p.1516-1523
17.
Methotrexate reduces immunogenicity in adalimumab treated rheumatoid arthritis patients in a dose dependent manner
by Krieckaert, Charlotte L
Annals of the rheumatic diseases, 2012, Vol.71 (11), p.1914-1915
18.
Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, doubl...
by Lawitz, Eric, Prof
The Lancet infectious diseases, 2013, Vol.13 (5), p.401-408
19.
Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial
by Houssiau, Frédéric A
Annals of the rheumatic diseases, 2010, Vol.69 (12), p.2083-2089
20.
Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled t...
by Song, I-H
Annals of the rheumatic diseases, 2011, Vol.70 (4), p.590-596
